Showing results (571-580 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|February 9, 2017
Erratum: Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum]Clinicoeconomics and Outcomes Research : CEOR|October 13, 2022
Effect of Primary Health Care Expenditure on Universal Health Coverage: Evidence from Sub-Saharan AfricaKwadwo Arhin, Albert Opoku Frimpong, Kwame AcheampongClinicoeconomics and Outcomes Research : CEOR|November 10, 2018
Sacroiliac joint fusion health care cost comparison prior to and following surgery: an administrative claims analysisErin K Buysman, Rachel Halpern, David W PollyClinicoeconomics and Outcomes Research : CEOR|March 14, 2019
Health care utilization and costs following amplified versus non-amplified molecular probe testing for symptomatic patients with suspected vulvovaginitis: a US commercial payer populationStacey J Ackerman, Tyler Knight, Peter M Wahl, et al.Clinicoeconomics and Outcomes Research : CEOR|August 27, 2019
Cost-effectiveness of adding Endocuff® to standard colonoscopies for interval colorectal cancer screeningTiffany M Yu, Alison Tradonsky, Jun Tang, et al.Clinicoeconomics and Outcomes Research : CEOR|March 11, 2014
Antibiotic expected effectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in SpainSantiago Grau, Virginia Lozano, Amparo Valladares, et al.Clinicoeconomics and Outcomes Research : CEOR|April 15, 2014
Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in EuropeSamira Toghanian, Marco Dibonaventura, Krister Järbrink, et al.Clinicoeconomics and Outcomes Research : CEOR|March 6, 2014
Duloxetine treatment adherence across mental health and chronic pain conditionsStephen L Able, Zhanglin Cui, Wei ShenClinicoeconomics and Outcomes Research : CEOR|June 30, 2012
Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in SpainMarina De Salas-Cansado, José M Olivares, Enrique Alvarez, et al.Clinicoeconomics and Outcomes Research : CEOR|July 4, 2012
Retrospective US database analysis of drug utilization patterns, health care resource use, and costs associated with adjuvant interferon alfa-2b therapy for treatment of malignant melanoma following surgeryMichelle D Hackshaw, Arun Krishna, David J MauroPageof 102